KALV Stock Touches 52-Week Low at $8.20 Amid Market Challenges
In a challenging market environment, KalVista Pharmaceuticals, Inc. (NASDAQ:) stock has reached a 52-week low,...
In a challenging market environment, KalVista Pharmaceuticals, Inc. (NASDAQ:) stock has reached a 52-week low,...
President Prabowo Subianto gave his approval for the government to accept a $1 billion investment from the U.S. tech giant, according to people familiar with the matter.
The defense authorization bill has not failed to pass Congress in nearly six decades, but the Pentagon policy measure has become a battleground for cultural issues.
(Reuters) -The Bank of Japan kept interest rates unchanged on Thursday but one dissenting board...
By Rae Wee SINGAPORE (Reuters) -The dollar flirted with a two-year peak on Thursday after...
LONDON – South32 (OTC:) Limited (ASX / LSE / JSE: S32; ADR: SOUHY) has provided...
By Manya Saini and Niket Nishant (Reuters) -Buy now, pay later firm Sezzle’s shares plunged...
(Reuters) – A merger between Honda (NYSE:) and Nissan (OTC:) would not come with quick...
Investing.com — The Federal Reserve cut interest rates by 25 basis points on Wednesday, but...